TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
No popular reads data found
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
No popular reads data found
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsCOVID-19-treatment
World 5 years ago
Moderna's COVID-19 vaccine candidate moves into late-stage trial
Moderna Inc said on Monday it had started a late-stage trial to test the effectiveness of its COVID-19 vaccine candidate, the first such study under the Trump administration's program to speed development of measures against the novel coronavirus.
World 5 years ago
China's Sinopharm says coronavirus vaccine could be ready by year-end: State media
A coronavirus vaccine candidate developed by China National Pharmaceutical Group (Sinopharm) could be ready for public use by the end of this year, state media reported on Wednesday, ahead of a previous expectation it may become available in 2021.
World 5 years ago
Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trial
German biotech BioNTech and US drugmaker Pfizer Inc on Monday said data from an early-stage trial of their experimental coronavirus vaccine showed that it prompted an immune response and was well-tolerated, similar to results seen in prior early test.
World 5 years ago
Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva
Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc and BioNTech, and French group Valneva, the business ministry said on Monday.
